The global bronchial biopsy devices market size was accounted for USD 673.38 million in 2024, grew to USD 723.35 million in 2025 and is projected to surpass around USD 1,377.57 million by 2034, representing a CAGR of 7.42% between 2025 and 2034. The North America bronchial biopsy devices market size is calculated at USD 276.09 million in 2024 and is expected to grow at a CAGR of 7.55% during the forecast year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Bronchial Biopsy Devices Industry Impact
5.2. COVID-19 Impact Assessment for the Industry
5.3. COVID-19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Bronchial Biopsy Devices Market Revenue and Volume, by Product, 2025-2034
8.1.1. Biopsy Forceps
8.1.1.1. Market Revenue and Volume Forecast (2022-2034)
8.1.2. Transbronchial Needle Aspiration (TBNA) Needles
8.1.2.1. Market Revenue and Volume Forecast (2022-2034)
8.1.3. Cytology Brushes
8.1.3.1. Market Revenue and Volume Forecast (2022-2034)
8.1.4. Cryobiopsy Devices (Cryoprobes)
8.1.4.1. Market Revenue and Volume Forecast (2022-2034)
9.1. North America
9.1.1. Market Revenue and Volume Forecast, by Product (2022-2034)
9.1.2. U.S.
9.1.2.1. Market Revenue and Volume Forecast, by Product (2022-2034)
9.1.3. Rest of North America
9.1.3.1. Market Revenue and Volume Forecast, by Product (2022-2034)
9.2. Europe
9.2.1. Market Revenue and Volume Forecast, by Product (2022-2034)
9.2.2. UK
9.2.2.1. Market Revenue and Volume Forecast, by Product (2022-2034)
9.2.3. Germany
9.2.3.1. Market Revenue and Volume Forecast, by Product (2022-2034)
9.2.4. France
9.2.4.1. Market Revenue and Volume Forecast, by Product (2022-2034)
9.2.5. Rest of Europe
9.2.5.1. Market Revenue and Volume Forecast, by Product (2022-2034)
9.3. APAC
9.3.1. Market Revenue and Volume Forecast, by Product (2022-2034)
9.3.2. India
9.3.2.1. Market Revenue and Volume Forecast, by Product (2022-2034)
9.3.3. China
9.3.3.1. Market Revenue and Volume Forecast, by Product (2022-2034)
9.3.4. Japan
9.3.4.1. Market Revenue and Volume Forecast, by Product (2022-2034)
9.3.5. Rest of APAC
9.3.5.1. Market Revenue and Volume Forecast, by Product (2022-2034)
9.4. MEA
9.4.1. Market Revenue and Volume Forecast, by Product (2022-2034)
9.4.2. GCC
9.4.2.1. Market Revenue and Volume Forecast, by Product (2022-2034)
9.4.3. North Africa
9.4.3.1. Market Revenue and Volume Forecast, by Product (2022-2034)
9.4.4. South Africa
9.4.4.1. Market Revenue and Volume Forecast, by Product (2022-2034)
9.4.5. Rest of MEA
9.4.5.1. Market Revenue and Volume Forecast, by Product (2022-2034)
9.5. Latin America
9.5.1. Market Revenue and Volume Forecast, by Product (2022-2034)
9.5.2. Brazil
9.5.2.1. Market Revenue and Volume Forecast, by Product (2022-2034)
9.5.3. Rest of LATAM
9.5.3.1. Market Revenue and Volume Forecast, by Product (2022-2034)
10.1. Medtronic
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Boston Scientific Corporation
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. CONMED Corporation
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Olympus Corporation
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Becton, Dickinson and Company (BD)
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. Cook Medical
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. Telemed Systems, Inc.
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. HOBBS MEDICAL INC
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. Argon Medical Devices (WEIGAO GROUP)
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. Horizons International Corp.
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
12.1. About Us
12.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample